CIK 0001873835 · <br>Emerging growth company
Immix Biopharma, Inc.
Sign in to watch- Ticker
- IMMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454869378
- Phone
- (888) 958-1084
- Business address
- 11400 WEST OLYMPIC BLVD., SUITE 200, LOS ANGELES, CA, 90064
- Former names
- Immix Biopharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-14 | Senn Sean 10% owner | Sale | −200 | $2.75 | $550 | 899,800 |
| 2022-07-14 | Adams Helen C. Director | Grant or award · Stock Options | +16,000 | 53,500 | ||
| 2022-07-14 | Marquet Magda Director | Grant or award · Stock Options | +16,000 | 76,000 | ||
| 2022-07-14 | Rachman Ilya M CEO and Chairman | Grant or award · Stock Options | +250,000 | 520,000 | ||
| 2022-07-14 | Ng Carey Director | Grant or award · Stock Options | +16,000 | 16,000 | ||
| 2022-07-14 | BUCHAN MELISSA JANE Director | Grant or award · Stock Options | +16,000 | 46,000 | ||
| 2022-07-14 | Hsu Jason Director | Grant or award · Stock Options | +16,000 | 16,000 | ||
| 2022-07-14 | Morris Gabriel S CFO | Grant or award · Stock Options | +250,000 | 716,500 | ||
| 2021-12-20 | Hsu Jason Director | Conversion | +3,915,913 | $0.85 | $3.3M | 3,915,913 |
| 2021-12-20 | Hsu Jason Director | Purchase | +50,000 | $5.00 | $250K | 50,000 |
| 2021-12-20 | Hsu Jason Director | Conversion · Convertible Note | −0 | 0 | ||
| 2021-12-20 | Rachman Ilya M CEO and Chairman | Purchase | +2,500 | $5.00 | $13K | 902,500 |
| 2021-12-20 | Torchilin Vladimir P Scientific Co-Founder | Purchase | +3,000 | $5.00 | $15K | 905,200 |
| 2021-12-20 | Morris Gabriel S Chief Financial Officer | Conversion | +74,116 | $0.85 | $63K | 74,116 |
| 2021-12-20 | Morris Gabriel S Chief Financial Officer | Conversion | +123,527 | $0.85 | $105K | 123,527 |
| 2021-12-20 | Morris Gabriel S Chief Financial Officer | Conversion | +123,176 | $0.85 | $105K | 246,703 |
| 2021-12-20 | Morris Gabriel S Chief Financial Officer | Purchase | +2,000 | $5.00 | $10K | 76,116 |
| 2021-12-20 | Morris Gabriel S Chief Financial Officer | Conversion · Convertible Note | −0 | 0 | ||
| 2021-12-20 | Morris Gabriel S Chief Financial Officer | Conversion · Convertible Note | −0 | 0 | ||
| 2021-12-20 | Morris Gabriel S Chief Financial Officer | Conversion · Convertible Note | −0 | 0 |
Page 6 of 7 · 124 trades